CN105884692A - 5位取代手性海因的制备方法 - Google Patents

5位取代手性海因的制备方法 Download PDF

Info

Publication number
CN105884692A
CN105884692A CN201610284688.XA CN201610284688A CN105884692A CN 105884692 A CN105884692 A CN 105884692A CN 201610284688 A CN201610284688 A CN 201610284688A CN 105884692 A CN105884692 A CN 105884692A
Authority
CN
China
Prior art keywords
chiral
formula
substituted
hydantoin
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610284688.XA
Other languages
English (en)
Inventor
马保德
王晓光
杜升华
王宇
黄超群
罗亮明
熊莉莉
王艳丽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HUNAN HAILI CHEMICAL CO Ltd
Original Assignee
HUNAN HAILI CHEMICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HUNAN HAILI CHEMICAL CO Ltd filed Critical HUNAN HAILI CHEMICAL CO Ltd
Priority to CN201610284688.XA priority Critical patent/CN105884692A/zh
Publication of CN105884692A publication Critical patent/CN105884692A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/74Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Abstract

本发明公开了一种乙内酰脲衍生的环外烯烃的不对称催化氢化直接制备5位取代手性海因化合物的方法。5位取代手性海因化合物的化学结构式用式(I)表示:本发明的化学反应方程式如下:

Description

5位取代手性海因的制备方法
技术领域
本发明涉及一种5位取代手性海因化合物的制备方法。
背景技术
海因(乙内酰脲)最早由Baeyer于1861年通过尿囊素加氢而获得。科学家通过各种途径发现或者合成了大量海因衍生物,很多这类衍生物具有独特的药理和生物活性,被广泛的应用于医药、农药等领域。近年来。随着手性科学的发展,科学家们也发现和合成了许多具有单一手性的海因衍生物,很多这些化合物都表现出了优异的生物活性。因此高效的合成手性海因化合物不仅具有重要的科学意义,同时还具有重要的应用价值。迄今为止,文献已经报道了几类有效合成手性海因化合物的方法,其中主要包括手性拆分法、酶催化法、定向合成法等(Bulletin des Societes Chimiques Belges,96(6),459-65;1987;Biotechnology Letters,14(2),99-104;1992;Chemistry Letters,32(4),372-373;2003;Journal of Labelled Compounds andRadiopharmaceuticals,54(2),110-114;2011;Journal of Organic Chemistry,79(21),10132-10142;2014)。这些方法反应步骤长,原子利用率低,不易于工业化。
发明内容
本发明提供一种乙内酰脲衍生的环外烯烃的不对称催化氢化直接制备5位取代手性海因化合物的方法。5位取代手性海因化合物的化学结构式如式(I)所示:
式(I)中:
R是H或C1~C8烷基、C1~C8取代烷基、苯基、取代苯基、杂环芳基、取代杂环芳基。5位手性碳原子的构型是R或S,或者是R/S任意比例的混合物。
本发明的化学反应方程式如下:
反应式中化合物(Ⅱ)为乙内酰脲衍生的环外烯烃,其中,R是H、C1~C8烷基、C1~C8取代烷基、苯基、取代苯基、杂环芳基、取代杂环芳基。所述烯烃的构型可以是Z式或E式或Z式E式任何比例的混合物。(Ⅱ)可以由公开报道的文献方法制备(Molecules,18,5142-5154;2013;Tetrahedron,67(45),8639-8647;2011;Journal of Organic Chemistry,80(8),3929-3939;2015)。
反应式中化合物(Ⅲ)为催化剂,催化剂是手性双膦配体的金属配合物。手性双膦配体包括BINAP或BINAPO,H8-BINAP,P-Phos,,MeO-BINAP,SEGPhos,Cn-TunaPhos,SDP。M是金属铑离子或钯离子。配阴离子L是卤素根或醋酸根、三氟醋酸根、四氟硼根、六氟磷根、磷酸根。所述催化剂(Ⅲ)与底物(Ⅱ)的摩尔比是0.01%-10%︰1。催化剂(Ⅲ)可以提前制备,制备方法是将手性配体与相应的金属盐在合适溶剂中配位,配位完毕后脱除溶剂,得到相应催化剂(Ⅲ);催化剂(Ⅲ)也可以在反应体系中原位生成,即将手性配体和相应金属盐直接添加到反应体系中(Journal of Organic Chemistry,59,3064-3076;1994;Journal ofAmerican Chemistry Society,132(26),8909-8911)。手性双膦配体的化学结构式如下:
反应在酸性添加剂存在下有效进行,酸性添加剂包括醋酸或三氟醋酸、樟脑磺酸、磷酸。酸性添加剂与催化剂的摩尔比是0.1-10︰1。
反应在极性溶剂中进行,极性溶剂是指甲醇、乙醇、三氟乙醇、异丙醇、全氟异丙醇、二甲基亚砜中的一种或者两种混合物。
反应温度为10-100℃。反应压力为0.1-10MPa。
本发明通过乙内酰脲衍生的环外烯烃的不对称催化氢化技术,直接制备得到5位取代手性海因化合物。本发明与现有技术相比具有手性增殖、高效高选择性、原子经济性、绿色无污染、易于工业化等特点。
以下通过具体的实施例对本发明上述的内容作进一步的详细说明,但本发明不局限于实施例。
具体实施方式
实施例1
在带磁子的玻璃试管中加入188mg 5-亚苄基海因(1mmol),7.5mg(R)-BINAP(0.012mmol),3.3mg三氟醋酸钯(0.01mmol),7.0mg(S)-1,1'-联萘基-2,2'-双磷酸氢酯(0.02mmol)。氮气保护下加入10mL乙醇,充入3MPa氢气,60℃反应8小时。反应结束后,自然冷却至室温,小心放掉氢气,脱去大部分有机溶剂,加入5mL溶剂(乙醇/石油醚=1/2,v/v)重结晶。过滤后得产品175mg,收率93.1%,纯度96.6%,对映选择性(ee)为46%。
实施例2
在带磁子的玻璃试管中加入202mg 5-(2-甲基-亚苄基)-海因(1mmol),7.5mg(R)-BINAP(0.012mmol),2.3mg醋酸钯(0.01mmol),12mg(S)-3,3'-(1-萘基)-1,1'-联萘基-2,2'-双磷酸氢酯(0.02mmol)。氮气保护下加入10mL三氟乙醇,充入5MPa氢气,70℃反应8小时。反应结束后,自然冷却至室温,小心放掉氢气,脱去大部分有机溶剂,加入5mL溶剂(乙醇/石油醚=1/2,v/v)重结晶。过滤后得产品185mg,收率90.7%,纯度97.2%,对映选择性(ee)为90%。
实施例3
在带磁子的玻璃试管中加入218mg 5-(2-甲氧基-亚苄基)-海因(1mmol),7.0mg(R)-SDP(0.012mmol),3.3mg三氟醋酸钯(0.01mmol),9.2mg(S)-樟脑磺酸(0.04mmol)。氮气保护下加入10mL全氟异丙醇,充入2MPa氢气,80℃反应8小时。反应结束后,自然冷却至室温,小心放掉氢气,脱去大部分有机溶剂,加入5mL溶剂(乙醇/石油醚=1/2,v/v)重结晶。过滤后得产品205mg,收率93.2%,纯度95.7%,对映选择性(ee)为88%。
实施例4
在带磁子的玻璃试管中加入189mg 5-(3-吡啶叉基)-海因(1mmol),7.5mg(S)-BINAP(0.012mmol),3.3mg醋酸钯(0.01mmol),72mg醋酸(1.2mmol)。氮气保护下加入10mL二甲基亚砜,充入5MPa氢气,50℃反应8小时。反应结束后,自然冷却至室温,小心放掉氢气,脱去大部分有机溶剂,加入5mL溶剂(乙醇/石油醚=1/2,v/v)重结晶。过滤后得产品154mg,收率80.6%,纯度98.1%,对映选择性(ee)为49%。
实施例5
在带磁子的玻璃试管中加入140mg 5-丙叉基海因(1mmol),7.3mg(R)-SEGPhos(0.012mmol),3.3mg三氟醋酸钯(0.01mmol),12mg(S)-3,3'-(1-萘基)-1,1'-联萘基-2,2'-双磷酸氢酯(0.02mmol)。氮气保护下加入10mL全氟异丙醇,充入2MPa氢气,40℃反应6小时。反应结束后,自然冷却至室温,小心放掉氢气,脱去大部分有机溶剂,加入5mL溶剂(甲醇/石油醚=1/2,v/v)重结晶。过滤后得产品125mg,收率88.0%,纯度93.6%,对映选择性(ee)为67%。
实施例6
在带磁子的玻璃试管中加入204mg 5-(4-羟基-亚苄基)-海因(1mmol),7.5mg(R)-BINAP(0.012mmol),3.3mg三氟醋酸钯(0.01mmol),4.6mg(S)-樟脑磺酸(0.02mmol)。氮气保护下加入10mL全氟异丙醇,充入4MPa氢气,80℃反应8小时。反应结束后,自然冷却至室温,小心放掉氢气,脱去大部分有机溶剂,加入5mL溶剂(乙醇/石油醚=1/1,v/v)重结晶。过滤后得产品195mg,收率94.7%,纯度95.5%,对映选择性(ee)为57%。
实施例7
在带磁子的玻璃试管中加入222mg 5-(4-氯-亚苄基)-海因(1mmol),7.5mg(R)-BINAP(0.012mmol),3.3mg三氟醋酸钯(0.01mmol),2.4mg三氟醋酸(0.02mmol)。氮气保护下加入10mL三氟乙醇,充入6MPa氢气,80℃反应8小时。反应结束后,自然冷却至室温,小心放掉氢气,脱去大部分有机溶剂,加入5mL溶剂(乙醇/石油醚=1/1,v/v)重结晶。过滤后得产品201mg,收率89.7%,纯度96.8%,对映选择性(ee)为45%。
实施例8
在带磁子的玻璃试管中加入232mg 5-(2-乙氧基-亚苄基)-海因(1mmol),7.5mg(R)-BINAP(0.012mmol),4.1mg双(1,5-环辛二烯)铑四氟化硼盐(0.01mmol),7.0mg(S)-1,1'-联萘基-2,2'-双磷酸氢酯(0.02mmol)。氮气保护下加入10mL三氟乙醇,充入2MPa氢气,50℃反应8小时。反应结束后,自然冷却至室温,小心放掉氢气,脱去大部分有机溶剂,加入5mL溶剂(甲醇/石油醚=1/1,v/v)重结晶。过滤后得产品221mg,收率94.4%,纯度93.7%,对映选择性(ee)为62%。
实施例9
在带磁子的玻璃试管中加入260mg 5-(2-丁氧基-亚苄基)-海因(1mmol),7.8mg(R)-BINAPO(0.012mmol),4.1mg双(1,5-环辛二烯)铑四氟化硼盐(0.01mmol),6.0mg醋酸(0.1mmol)。氮气保护下加入10mL甲醇,充入10MPa氢气,10℃反应24小时。反应结束后,自然冷却至室温,小心放掉氢气,脱去大部分有机溶剂,加入5mL溶剂(甲醇/石油醚=1/1,v/v)重结晶。过滤后得产品244mg,收率93.1%,纯度94.9%,对映选择性(ee)为67%。
实施例10
在带磁子的玻璃试管中加入222mg 5-(3-氯-亚苄基)-海因(1mmol),7.0mg(S)-MeOBIPHEP(0.012mmol),3.3mg三氟醋酸钯(0.01mmol),7.0mg(R)-1,1'-联萘基-2,2'-双磷酸氢酯(0.02mmol)。氮气保护下加入10mL异丙醇,充入0.1MPa氢气,60℃反应8小时。反应结束后,自然冷却至室温,小心放掉氢气,脱去大部分有机溶剂,加入5mL溶剂(甲醇/石油醚=1/1,v/v)重结晶。过滤后得产品201mg,收率89.7%,纯度96.6%,对映选择性(ee)为48%。
实施例11
在带磁子的玻璃试管中加入222mg 5-(2-氯-亚苄基)-海因(1mmol),7.7mg(R)-P-Phos(0.012mmol),3.3mg三氟醋酸钯(0.01mmol),7.0mg(S)-1,1'-联萘基-2,2'-双磷酸氢酯(0.02mmol)。氮气保护下加入10mL三氟乙醇,充入5MPa氢气,100℃反应6小时。反应结束后,自然冷却至室温,小心放掉氢气,脱去大部分有机溶剂,加入5mL溶剂(甲醇/石油醚=1/1,v/v)重结晶。过滤后得产品211mg,收率94.2%,纯度97.8%,对映选择性(ee)为52%。

Claims (2)

1.制备5位取代手性海因化合物的方法,其特征在于通过乙内酰脲衍生的环外烯烃的不对称催化氢化法直接制备得到,5位取代手性海因化合物的化学结构式如式(I)所示:
式(I)中:
R是H或C1~C8烷基、C1~C8取代烷基、苯基、取代苯基、杂环芳基、取代杂环芳基;5位手性碳原子的构型是R或S,或者是R/S任意比例的混合物,
化学反应方程式如下:
反应式中化合物(Ⅱ)为乙内酰脲衍生的环外烯烃,其中,R是H、C1~C8烷基、C1~C8取代烷基、苯基、取代苯基、杂环芳基、取代杂环芳基;
反应式中化合物(Ⅲ)为催化剂,催化剂是手性双膦配体的金属配合物,手性双膦配体包括BINAP或BINAPO,H8-BINAP,P-Phos,,MeO-BINAP,SEGPhos,Cn-TunaPhos,SDP;M是金属铑离子或钯离子;配阴离子L是卤素根或醋酸根、三氟醋酸根、四氟硼根、六氟磷根、磷酸根;手性双膦配体的化学结构式如下:
所述催化剂(Ⅲ)与乙内酰脲衍生的环外烯烃(II)的投料摩尔比是0.0.01%-10%︰1;
反应在酸性添加剂存在下进行,所述酸性添加剂包括醋酸或三氟醋酸、樟脑磺酸、磷酸,酸性添加剂与催化剂的投料摩尔比是0.1-10︰1;
反应在极性溶剂中进行,所述极性溶剂是指甲醇、乙醇、三氟乙醇、异丙醇、全氟异丙醇、二甲基亚砜中的一种或者两种混合物;
反应温度为10-100℃,反应压力为0.1-10MPa。
2.根据权利要求1所述制备5位取代手性海因化合物的方法,其特征在于所述烯烃的构型是Z式或E式或Z式E式任何比例的混合物。
CN201610284688.XA 2016-05-03 2016-05-03 5位取代手性海因的制备方法 Pending CN105884692A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610284688.XA CN105884692A (zh) 2016-05-03 2016-05-03 5位取代手性海因的制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610284688.XA CN105884692A (zh) 2016-05-03 2016-05-03 5位取代手性海因的制备方法

Publications (1)

Publication Number Publication Date
CN105884692A true CN105884692A (zh) 2016-08-24

Family

ID=56702064

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610284688.XA Pending CN105884692A (zh) 2016-05-03 2016-05-03 5位取代手性海因的制备方法

Country Status (1)

Country Link
CN (1) CN105884692A (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112358379A (zh) * 2020-11-09 2021-02-12 南方科技大学 一种光学纯s构型1,1-双-(4-氟苯基)-2-丙醇的制备方法
CN112574014A (zh) * 2019-09-29 2021-03-30 中国科学院大连化学物理研究所 一种钯催化不对称还原合成手性β-羟基酮的方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684735A (en) * 1985-07-01 1987-08-04 Stauffer Chemical Company Promotion of raney nickel hydrogenation catalyst

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684735A (en) * 1985-07-01 1987-08-04 Stauffer Chemical Company Promotion of raney nickel hydrogenation catalyst

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SEIJI TAKEUCHI, ET AL.: "Asymmetric Hydrogenation of N,N’-Dimethyl-5-alkylidene- and arylmethylenehydantoins Catalyzed by (Achiral Base)bis(dimethylglyoximato)cobalt(II)-Chiral Cocatalyst System", 《BULL. CHEM. SOC. JPN.》 *
STÉPHANIE GRACIA, ET AL.: "Enantioselective straightforward access to benzo[b]thiophene analogs of Azatoxin"", 《TETRAHEDRON LETTERS》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112574014A (zh) * 2019-09-29 2021-03-30 中国科学院大连化学物理研究所 一种钯催化不对称还原合成手性β-羟基酮的方法
CN112574014B (zh) * 2019-09-29 2022-03-11 中国科学院大连化学物理研究所 一种钯催化不对称还原合成手性β-羟基酮的方法
CN112358379A (zh) * 2020-11-09 2021-02-12 南方科技大学 一种光学纯s构型1,1-双-(4-氟苯基)-2-丙醇的制备方法

Similar Documents

Publication Publication Date Title
Li et al. Iron‐Catalyzed Ligand‐Free Three‐Component Coupling Reactions of Aldehydes, Terminal Alkynes, and Amines
Fleury‐Brégeot et al. Highlights of Transition Metal‐Catalyzed Asymmetric Hydrogenation of Imines
León et al. P‐Stereogenic Secondary Iminophosphorane Ligands and Their Rhodium (I) Complexes: Taking Advantage of NH/PH Tautomerism
JP5207445B2 (ja) 2−(アミノメチル)ピリジン及びフォスフィンを有するルテニウムの複合体、その調製方法、並びに触媒としての使用
Mannathan et al. Enantioselective intramolecular reductive Heck reaction with a palladium/monodentate phosphoramidite catalyst
US7754902B2 (en) Ruthenium(II) catalysts for use in stereoselective cyclopropanations
Olyaei et al. Recent advances in the synthesis and synthetic applications of Betti base (aminoalkylnaphthol) and bis-Betti base derivatives
Leñero et al. Heterolytic activation of dihydrogen by platinum and palladium complexes
Baratta et al. Pincer CNN ruthenium (II) complexes with oxygen-containing ligands (O2CR, OAr, OR, OSiR3, O3SCF3): Synthesis, structure, and catalytic activity in fast transfer hydrogenation
EP2279992A1 (en) Aluminum complex and use thereof
CN107866282A (zh) 一类含氮膦配体在烯烃氢甲酰化串联反应中的应用
CN105884692A (zh) 5位取代手性海因的制备方法
Cabrera et al. Diastereo-and enantioselective reductive amination of cycloaliphatic ketones by preformed chiral palladium complexes
CN105593220A (zh) 用于生产包含至少一个胺官能团的呋喃化合物的方法
CN112358379B (zh) 一种光学纯s构型1,1-双-(4-氟苯基)-2-丙醇的制备方法
Nirmala et al. Ruthenium (II) complexes incorporating salicylaldiminato-functionalized N-heterocyclic carbene ligands as efficient and versatile catalysts for hydration of organonitriles
CN109939737B (zh) 卡宾钴催化剂、其制备方法及其在催化氢化醛和酮化合物中的应用
CN104262374A (zh) 一种硼氢化胺盐的制备方法
CN110878099A (zh) 一种吡咯[1,2,α]吲哚生物碱衍生物的制备方法
Xue et al. Pentanuclear Gold (I) Cluster with an Axially Chiral Biaryl Center: Synthesis and Chiral Transformation
EP1414566A1 (en) Palladium catalysts
EP3016961B1 (en) Novel ruthenium catalysts and their use for asymmetric reduction of ketones
Ferraccioli Asymmetric Hydrogenation Catalyzed by Bifunctional Knolker Type Complexes
JP2007504104A (ja) ジエン−ビス−アコ−ロジウム(i)錯体、それらの調製プロセスおよび使用
Zirakzadeh et al. Iron (II) complexes featuring chiral PNNP diferrocene: Synthesis and characterization of potential hydrogenation catalysts

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20160824

RJ01 Rejection of invention patent application after publication